Product Information

ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION is a generic product labeled by Genus Lifesciences Inc., priced at $0.4688 per ML under NDC 64950037416. Its NADAC has been published 147 times since Dec 13, 2023.

FDA first approved this application before 1982.

The High Outlier badge above means this manufacturer's average price in the Acetaminophen and Codeine Phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION

Acetaminophen and Codeine Phosphate
$0.4688per ML
High Outlier
DEA Schedule CV

Strength

120; 12 mg/5mL; mg/5mL

NDC

64950037416

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

9/23/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA087508

FDA Approved

Before 1982

On Market Since

8/10/2023

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION has been published 147 times since Dec 13, 2023, and over the history we have for it it has risen 3135.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4688 per ML
All-time high$0.4770 (Apr 15, 2026)
All-time low$0.0145 (Dec 13, 2023)
52-week high$0.4770
52-week low$0.4492
Median price$0.4293
Average price$0.3846
Largest weekly change+2897.2% (Apr 17, 2024)
Weeks tracked147
Tracking sinceDec 13, 2023

Price History

1W

0.0%

1M

-0.1%

3M

-1.1%

6M

-1.7%

1Y

+4.4%

3Y

N/A

5Y

N/A

All

+3135.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen and Codeine Phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION, manufactured by Genus Lifesciences Inc., is $0.4688 per ML (NDC 64950037416), effective Sep 30, 2026.

How has the price of ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION changed over time?

Over the history we have for it, the NADAC for ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION has risen 3135.1%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION?

Since Dec 13, 2023, the NADAC for ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION has ranged from a low of $0.0145 (Dec 13, 2023) to a high of $0.4770 (Apr 15, 2026), with a median of $0.4293 per ML.

Are there cheaper alternatives to ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION?

No other NADAC-published product currently shares the active ingredient and strength of ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION?

ACETAMINOPHEN-CODEINE 120 MG-12 MG/5 ML SOLUTION (NDC 64950037416) is labeled by Genus Lifesciences Inc., and CMS classifies it as a generic product.